Immunotherapy-Related Pneumonitis in Lung Cancer


When it comes to immunotherapy-related adverse events, patients with lung cancer tend to have higher rates of pneumonitis than other cancer types, one nurse explains.

Oncology nurses need to look out for the signs of immunotherapy-related pneumonitis in their patients with lung cancer, as they have a higher rate of the adverse event than patients with other cancer types, according to Beth Sandy, MSN, CRNP, a nurse at the Abramson Cancer Center of University of Pennsylvania.


[L]ung cancer patients ... they have a higher rate of pneumonitis than other types of cancer where immunotherapy is utilized. For example, melanoma was the first tumor type where immunotherapy became a mainstay of treatment. But their pneumonitis rates, that pulmonary inflammation from immunotherapy, is really low. It's 1% or less.

[I]n lung cancer, if you look at some of the meta analyses, up to 13% of lung cancer patients can experience pneumonitis from immunotherapy. So that is something really to focus on in lung cancer patients is that inflammation, shortness of breath, that can be induced by immunotherapy.

And then the other [adverse events] are pretty typical that we see across tumor types like the endocrinopathies, the hypothyroidism, the colitis, nephritis and hepatitis are uncommon -- 1% to 3%. But they definitely happen, just [like] these other inflammatory [events] and then the [dermatologic] conditions again, less common in lung cancer, but more common in other tumor types. But something that we see frequently I saw one this week like a very strange kind of skin hypersensitivity almost reaction.

Related Videos
Colleen O’Leary, DNP, RN, AOCNS, EBP-C, LSSYB, in an interview with Oncology Nursing News.
Michelle H. Johann, DNP, RN, PHN, CPAN, WTA, in an interview with Oncology Nursing News explaining surgical path cards
Jessica MacIntyre, DNP, MBA, APRN, NP-C, AOCNP, in an interview with Oncology Nursing News
Andrea Wagner, M.S.N., RN, OCN, in an interview with Oncology Nursing News discussing her abstract on verbal orders for CRS.
John Rodriguez in an interview with Oncology Nursing News discussing his abstract on reducing nurse burnout
Alison Tray, of Hartford Healthcare, discusses her team's research on a multidisciplinary team approach to manage the cancer drug shortage
Cancer-Related Cognitive Impairment
Related Content
© 2024 MJH Life Sciences

All rights reserved.